Edition:
United States

People: Neogenomics Inc (NEO.OQ)

NEO.OQ on NASDAQ Stock Exchange Capital Market

13.89USD
13 Jul 2018
Change (% chg)

-- (--)
Prev Close
$13.89
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
115,617
52-wk High
$14.61
52-wk Low
$7.08

VanOort, Douglas 

Mr. Douglas M. VanOort (Doug) is Chairman of the Board of Directors, Chief Executive Officer of the Company. . VanOort has served as the Chairman of the Board of Directors and Chief Executive Officer of the Company since October 28, 2009. For seven months prior to October 2009, he served as Chairman of the Board of Directors, Executive Chairman and Interim Chief Executive Officer. Prior to joining the Company, Mr. VanOort was a General Partner with a private equity firm, and a Founding Managing Partner of a venture capital firm. From 1982 through 1999, Mr. VanOort served in various positions at Corning Incorporated (“Corning”) and at its spin-off company, Quest Diagnostics, Inc. (“Quest Diagnostics”). During the period from 1995 through 1999, he served as the Senior Vice President Operations for Quest Diagnostics which was then a $1.5 billion newly formed NYSE-traded Company. During the period of 1989 to 1995, he held senior executive positions at Corning Life Sciences, Inc., including Executive Vice President. Corning Life Sciences Inc. had revenues of approximately $2 billion and was spun-off in a public transaction to create both Quest Diagnostics and Covance, Inc. From 1982 to 1989, Mr. VanOort served in various executive positions at Corning, including Director of Mergers & Acquisitions. Mr. VanOort currently serves as a member of the Board of Directors of several privately-held companies, and is a principal owner of a privately-held retail hardware store chain. Mr. VanOort is a graduate of Bentley University.

Basic Compensation

Total Annual Compensation, USD 616,346
Restricted Stock Awards, USD 1,432,500
Long-Term Incentive Plans, USD --
All Other, USD 1,434,670
Fiscal Year Total, USD 3,483,510

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --